Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Lycera Corporation patents


Recent patent applications related to Lycera Corporation. Lycera Corporation is listed as an Agent/Assignee. Note: Lycera Corporation may have other listings under different names/spellings. We're not affiliated with Lycera Corporation, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "L" | Lycera Corporation-related inventors


Indazolyl thiadiazolamines and related compounds for inhibition of rho-associated protein kinase and the treatment of disease

The invention provides indazolyl thiadiazolamines and related compounds, pharmaceutical compositions, methods of inhibiting rho-associated protein kinase, and methods of treating inflammatory disorders, immune disorders, fibrotic disorders, and other medical disorders using such compounds. An exemplary indazolyl thiadiazolamine compound is an n-(5-[5-[(1h4ndazol-5-yl)amino]-1,3,4-thiadiazol-2-yl]pyridin-3-yl)acetamide compound.. ... Lycera Corporation

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of rorgamma activity and the treatment of disease

The invention provides certain bicylic heterocyclic compounds of the formula (i) or pharmaceutically acceptable salts thereof, wherein x1, x2, r1, r2, r3, r4, and cy are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds of the formula (i) or pharmaceutically acceptable salts thereof, and methods of using the compounds of the formula (i) or pharmaceutically acceptable salts thereof or pharmaceutical compositions comprising the same for treating diseases or conditions mediated by rorgammat.. ... Lycera Corporation

Trifluoromethyl pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof

The invention provides trifluoromethyl pyrazolyl guanidine compounds that inhibit f1f0-atpase, and methods of using trifluoromethyl pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.. . ... Lycera Corporation

Pyrazolyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof

The invention provides pyrazolyl guanidine compounds that inhibit f1fo-atpase, and methods of using pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.. . ... Lycera Corporation

Benzenesulfonamido and related compounds for use as agonists of rory and the treatment of disease

The invention provides benzenesulfonamido and related compounds, pharmaceutical compositions, methods of promoting rorγ activity, increasing the amount of il-17 in a subject, and treating cancer using such benzenesulfonamido and related compounds.. . ... Lycera Corporation

Tetrahydroquinoline sulfonamide and related compounds for use as agonists of rory and the treatment of disease

The invention provides tetrahydroquinoline sulfonamide compounds, tetrahydronaphthalene sulfonyl compounds, and related compounds, pharmaceutical compositions, methods of promoting rory activity, methods of increasing the amount of il-17 in a subject, and methods of treating cancer and other medical disorders using such compounds.. . ... Lycera Corporation

Adoptive cellular therapy using an agonist of retinoic acid receptor-related orphan receptor gamma & related therapeutic methods

The invention relates to medical therapy using an agonist of the retinoic acid receptor-related orphan receptor gamma (rorγ) and provides adoptive cellular therapies using an agonist of rorγ, populations of lymphocyte cells that have been exposed to an agonist of rorγ, populations of dendritic cells that have been exposed to an agonist of rorγ, pharmaceutical compositions, and methods for enhancing therapeutic effects of lymphocyte cells and/or dendritic cells in a patient by administering an agonist of rorγ to a patient.. . ... Lycera Corporation








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Lycera Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Lycera Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###